ONCO-TARGET Trial

Study Overview

A multi-center study evaluating a targeted therapy for patients with advanced non-small cell lung cancer who have specific genetic markers. This precision medicine approach aims to improve treatment outcomes.

Inclusion Criteria

• ✓Adults aged 18+ years
• ✓Confirmed NSCLC diagnosis
• ✓EGFR mutation positive
• ✓ECOG performance status 0-1

Exclusion Criteria

• ✗Prior treatment with EGFR inhibitors
• ✗Brain metastases
• ✗Severe liver dysfunction
• ✗Uncontrolled infection